194 related articles for article (PubMed ID: 1679366)
1. Multiple fluorescent ligands for dopamine receptors. I. Pharmacological characterization and receptor selectivity.
Barton AC; Kang HC; Rinaudo MS; Monsma FJ; Stewart-Fram RM; Macinko JA; Haugland RP; Ariano MA; Sibley DR
Brain Res; 1991 May; 547(2):199-207. PubMed ID: 1679366
[TBL] [Abstract][Full Text] [Related]
2. Multiple fluorescent ligands for dopamine receptors. II. Visualization in neural tissues.
Ariano MA; Kang HC; Haugland RP; Sibley DR
Brain Res; 1991 May; 547(2):208-22. PubMed ID: 1884196
[TBL] [Abstract][Full Text] [Related]
3. Characterization of novel fluorescent ligands with high affinity for D1 and D2 dopaminergic receptors.
Monsma FJ; Barton AC; Kang HC; Brassard DL; Haugland RP; Sibley DR
J Neurochem; 1989 May; 52(5):1641-4. PubMed ID: 2523470
[TBL] [Abstract][Full Text] [Related]
4. Fluorescent and biotin probes for dopamine receptors: D1 and D2 receptor affinity and selectivity.
Madras BK; Canfield DR; Pfaelzer C; Vittimberga FJ; Difiglia M; Aronin N; Bakthavachalam V; Baindur N; Neumeyer JL
Mol Pharmacol; 1990 Jun; 37(6):833-9. PubMed ID: 2141665
[TBL] [Abstract][Full Text] [Related]
5. Direct visualization and cellular localization of D1 and D2 dopamine receptors in rat forebrain by use of fluorescent ligands.
Ariano MA; Monsma FJ; Barton AC; Kang HC; Haugland RP; Sibley DR
Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8570-4. PubMed ID: 2479025
[TBL] [Abstract][Full Text] [Related]
6. Cellular distribution of dopamine D1 and D2 receptors in rat medial prefrontal cortex.
Vincent SL; Khan Y; Benes FM
J Neurosci; 1993 Jun; 13(6):2551-64. PubMed ID: 8501521
[TBL] [Abstract][Full Text] [Related]
7. Fluorescent probes for dopamine receptors: synthesis and characterization of fluorescein and 7-nitrobenz-2-oxa-1,3-diazol-4-yl conjugates of D-1 and D-2 receptor ligands.
Bakthavachalam V; Baindur N; Madras BK; Neumeyer JL
J Med Chem; 1991 Nov; 34(11):3235-41. PubMed ID: 1956042
[TBL] [Abstract][Full Text] [Related]
8. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
9. Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction.
Kozell LB; Machida CA; Neve RL; Neve KA
J Biol Chem; 1994 Dec; 269(48):30299-306. PubMed ID: 7982941
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of the D1- and D2-like dopamine receptors from the brain of the leopard frog, Rana pipiens.
Chu J; Wilczynski W; Wilcox RE
Brain Behav Evol; 2001 Jun; 57(6):328-42. PubMed ID: 11713387
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
Deveney AM; Waddington JL
Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors.
Knoerzer TA; Watts VJ; Nichols DE; Mailman RB
J Med Chem; 1995 Aug; 38(16):3062-70. PubMed ID: 7636869
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of D1 and D2 dopamine receptors in cultured neuroblastoma and retinoblastoma clonal cell lines.
Monsma FJ; Brassard DL; Sibley DR
Brain Res; 1989 Jul; 492(1-2):314-24. PubMed ID: 2665904
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes.
Tice MA; Hashemi T; Taylor LA; Duffy RA; McQuade RD
Pharmacol Biochem Behav; 1994 Nov; 49(3):567-71. PubMed ID: 7862709
[TBL] [Abstract][Full Text] [Related]
15. Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors.
Yang ZY; Perry B; Mukherjee J
Nucl Med Biol; 1996 Aug; 23(6):793-805. PubMed ID: 8940723
[TBL] [Abstract][Full Text] [Related]
16. Visualization of D1 dopamine receptors on living nucleus accumbens neurons and their colocalization with D2 receptors.
Shetreat ME; Lin L; Wong AC; Rayport S
J Neurochem; 1996 Apr; 66(4):1475-82. PubMed ID: 8627301
[TBL] [Abstract][Full Text] [Related]
17. trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist.
Brewster WK; Nichols DE; Riggs RM; Mottola DM; Lovenberg TW; Lewis MH; Mailman RB
J Med Chem; 1990 Jun; 33(6):1756-64. PubMed ID: 1971308
[TBL] [Abstract][Full Text] [Related]
18. Identification of the binding subunit of the D1-dopamine receptor by photoaffinity crosslinking.
Amlaiky N; Berger JG; Chang W; McQuade RJ; Caron MG
Mol Pharmacol; 1987 Feb; 31(2):129-34. PubMed ID: 3807891
[TBL] [Abstract][Full Text] [Related]
19. Prolonged D2 antidopaminergic activity of alkylating and nonalkylating derivatives of spiperone in rat brain.
Baldessarini RJ; Kula NS; Campbell A; Bakthavachalam V; Yuan J; Neumeyer JL
Mol Pharmacol; 1992 Nov; 42(5):856-63. PubMed ID: 1435753
[TBL] [Abstract][Full Text] [Related]
20. Behavioral effects of D1 and D2 dopamine receptor antagonists in squirrel monkeys.
Bergman J; Madras BK; Spealman RD
J Pharmacol Exp Ther; 1991 Sep; 258(3):910-7. PubMed ID: 1890625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
